Management of Depression in Patients With Cancer: A Clinical Practice Guideline

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

This report updates the Cancer Care Ontario Program in Evidence-Based Care guideline for the management of depression in adult patients with cancer. This guideline covers pharmacologic, psychological, and collaborative care interventions, with a focus on integrating practical management tools to assist clinicians in delivering appropriate treatments for depression in patients with cancer.

Related collections

Most cited references 47

Record: found
Abstract: not found
Article: not found

AGREE II: advancing guideline development, reporting and evaluation in health care.

M. Brouwers, M E Kho, G P Browman … (2010)

0 comments Cited 1039 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Effect of telecare management on pain and depression in patients with cancer: a randomized trial.

Kurt Kroenke, Dale Theobald, Jingwei Wu … (2010)

Pain and depression are 2 of the most prevalent and treatable cancer-related symptoms, yet they frequently go unrecognized, undertreated, or both. To determine whether centralized telephone-based care management coupled with automated symptom monitoring can improve depression and pain in patients with cancer. Randomized controlled trial conducted in 16 community-based urban and rural oncology practices involved in the Indiana Cancer Pain and Depression (INCPAD) trial. Recruitment occurred from March 2006 through August 2008 and follow-up concluded in August 2009. The participating patients had depression (Patient Health Questionnaire-9 score > or = 10), cancer-related pain (Brief Pain Inventory [BPI] worst pain score > or = 6), or both. The 202 patients randomly assigned to receive the intervention and 203 to receive usual care were stratified by symptom type. Patients in the intervention group received centralized telecare management by a nurse-physician specialist team coupled with automated home-based symptom monitoring by interactive voice recording or Internet. Blinded assessment at baseline and at months 1, 3, 6, and 12 for depression (20-item Hopkins Symptom Checklist [HSCL-20]) and pain (BPI) severity. Of the 405 participants enrolled in the study, 131 had depression only, 96 had pain only, and 178 had both depression and pain. Of the 274 patients with pain, 137 patients in the intervention group had greater improvements in BPI pain severity over the 12 months of the trial whether measured as a continuous severity score or as a categorical pain responder (> or = 30% decrease in BPI) than the 137 patients in the usual-care group (P or = 50% decrease in HSCL) than the 155 patients in the usual care group (P < .001 for both). The standardized effect size for between-group differences at 3 and 12 months was 0.67 (95% confidence interval [CI], 0.33-1.02) and 0.39 (95% CI, 0.01-0.77) for pain, and 0.42 (95% CI, 0.16-0.69) and 0.41 (95% CI, 0.08-0.72) for depression. Centralized telecare management coupled with automated symptom monitoring resulted in improved pain and depression outcomes in cancer patients receiving care in geographically dispersed urban and rural oncology practices. clinicaltrials.gov Identifier: NCT00313573.

0 comments Cited 89 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Depression and degree of acceptance of adjuvant cytotoxic drugs.

M Colleoni, M Mandala, G Peruzzotti … (2000)

An interaction between psychological attitude and outcome in early-stage breast cancer has been postulated, with a possible explanation related to the presumed tendency of depressed patients to be less proactive in obtaining health care. We report on the degree of acceptance of adjuvant chemotherapy in patients with breast cancer who have concomitant depression. Only 20 (51.3%) of the study group accepted and received the proposed chemotherapy compared with 75 (92.2%) of the control group (p<0.0001). Treatment of depression might be essential for tailoring adjuvant treatments with chemotherapy.

0 comments Cited 75 times – based on 0 reviews      Review now

Bookmark

All references

Author and article information

Journal

Title: Journal of Oncology Practice

Abbreviated Title: JOP

Publisher: American Society of Clinical Oncology (ASCO)

ISSN (Print): 1554-7477

ISSN (Electronic): 1935-469X

Publication date Created: August 2016

Publication date (Print): August 2016

Volume: 12

Issue: 8

Pages: 747-756

Affiliations

[1 ]Princess Margaret Cancer Centre, University Health Network; Cancer Care Ontario; and University of Toronto, Toronto; Cancer Care Ontario Program in Evidence-Based Care, McMaster University, Hamilton; Trillium Health Partners, Mississauga Halton-Central West Regional Cancer Program, Mississauga; Ottawa Hospital Cancer Centre, Ottawa; Stronach Regional Cancer Centre and Southlake Regional Health Centre, Newmarket; and Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada

Article

DOI: 10.1200/JOP.2016.011072

PubMed ID: 27382000

SO-VID: 8a8c8e07-91a1-4ec6-ad12-d55aaff97a35

History

Data availability:

Comments

Comment on this article

scite_

Cited by 27

See all cited by

Most referenced authors 1,168

See all reference authors

- Version 1

Management of Depression in Patients With Cancer: A Clinical Practice Guideline

Read this article at

Abstract

Related collections

Citation Behaviour and Practice

Most cited references 47

AGREE II: advancing guideline development, reporting and evaluation in health care.

Effect of telecare management on pain and depression in patients with cancer: a randomized trial.

Depression and degree of acceptance of adjuvant cytotoxic drugs.

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Similar content 1,434

Cited by 27

Most referenced authors 1,168